Unknown

Dataset Information

0

Single step reconstitution of multifunctional high-density lipoprotein-derived nanomaterials using microfluidics.


ABSTRACT: High-density lipoprotein (HDL) is a natural nanoparticle that transports peripheral cholesterol to the liver. Reconstituted high-density lipoprotein (rHDL) exhibits antiatherothrombotic properties and is being considered as a natural treatment for cardiovascular diseases. Furthermore, HDL nanoparticle platforms have been created for targeted delivery of therapeutic and diagnostic agents. The current methods for HDL reconstitution involve lengthy procedures that are challenging to scale up. A central need in the synthesis of rHDL, and multifunctional nanomaterials in general, is to establish large-scale production of reproducible and homogeneous batches in a simple and efficient fashion. Here, we present a large-scale microfluidics-based manufacturing method for single-step synthesis of HDL-mimicking nanomaterials (?HDL). ?HDL is shown to have the same properties (e.g., size, morphology, bioactivity) as conventionally reconstituted HDL and native HDL. In addition, we were able to incorporate simvastatin (a hydrophobic drug) into ?HDL, as well as gold, iron oxide, quantum dot nanocrystals or fluorophores to enable its detection by computed tomography (CT), magnetic resonance imaging (MRI), or fluorescence microscopy, respectively. Our approach may contribute to effective development and optimization of lipoprotein-based nanomaterials for medical imaging and drug delivery.

SUBMITTER: Kim Y 

PROVIDER: S-EPMC4104519 | biostudies-literature | 2013 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications


High-density lipoprotein (HDL) is a natural nanoparticle that transports peripheral cholesterol to the liver. Reconstituted high-density lipoprotein (rHDL) exhibits antiatherothrombotic properties and is being considered as a natural treatment for cardiovascular diseases. Furthermore, HDL nanoparticle platforms have been created for targeted delivery of therapeutic and diagnostic agents. The current methods for HDL reconstitution involve lengthy procedures that are challenging to scale up. A cen  ...[more]

Similar Datasets

| S-EPMC3582183 | biostudies-literature
2020-08-31 | GSE156800 | GEO
| S-EPMC4617360 | biostudies-literature
| S-EPMC8478306 | biostudies-literature
| S-EPMC5831354 | biostudies-literature
| S-EPMC7295173 | biostudies-literature
| S-EPMC4918468 | biostudies-other
| S-EPMC2843502 | biostudies-literature
| S-EPMC10323641 | biostudies-literature
| S-EPMC3958961 | biostudies-literature